Scientific article
English

Need for additional trials of primary prophylaxis in patients with high-risk antiphospholipid antibody profiles: comment on the article by Erkan et al

Published in

Arthritis and rheumatism, vol. 58, no. 2, p. 635-636

Publication date

2008

Keywords

  • Anti-Inflammatory Agents, Non-Steroidal/therapeutic use
  • Antibodies, Antiphospholipid/blood
  • Antiphospholipid Syndrome/drug therapy/epidemiology/immunology
  • Aspirin/therapeutic use
  • Humans
  • Risk Factors
  • Thrombosis/epidemiology/immunology/prevention & control

Note

With author reply (p. 636) - Comment on: Erkan D, Harrison MJ, Levy R, Peterson M, Petri M, Sammaritano L, Unalp-Arida A, Vilela V, Yazici Y, Lockshin MD. Aspirin for primary thrombosis prevention in the antiphospholipid syndrome: a randomized, double-blind, placebo-controlled trial in asymptomatic antiphospholipid antibody-positive individuals. Arthritis Rheum. 2007 Jul;56(7):2382-91.

Citation (ISO format)

WAHL, Denis, LECOMPTE, Thomas Pierre, BOUNAMEAUX, Henri. Need for additional trials of primary prophylaxis in patients with high-risk antiphospholipid antibody profiles: comment on the article by Erkan et al. In: Arthritis and rheumatism, 2008, vol. 58, n° 2, p. 635–636. doi: 10.1002/art.23160

Main files (1)

Article (Accepted version)

Identifiers

Journal ISSN

0004-3591
658views
0downloads

Technical informations

Creation

29/05/2009 12:36:00

First validation

29/05/2009 12:36:00

Update

09/02/2026 14:34:48

Status update

09/02/2026 14:34:48

Last indexation

20/04/2026 15:26:19
All rights reserved by Archive ouverte UNIGE and the University of Geneva
OpenAIRE Indexed & Validated